Floatz logo

50 assets in Anaplastic Large Cell Lymphoma

Therapeutic assets addressing Anaplastic Large Cell Lymphoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Crizotinib
Anaplastic Large Cell Lymphoma
PfizerP4BBB (75)
Adriamycin
Anaplastic Large Cell Lymphoma
City of Hope Medical CenterP4BBB (74)
Brentuximab Vedotin
Anaplastic Large Cell Lymphoma
Seagen Inc.P3BBB (72)
Cyclophosphamide
Anaplastic Large Cell Lymphoma
National Cancer Institute (NCI)P4BBB (72)
Etoposide
Anaplastic Large Cell Lymphoma
City of Hope Medical CenterP4BB (71)
Dexasone
Anaplastic Large Cell Lymphoma
Children's Cancer Group, ChinaP4BB (70)
Fludarabine
Anaplastic Large Cell Lymphoma
National Cancer Institute (NCI)P2BB (70)
Nivestim
Anaplastic Large Cell Lymphoma
Fred Hutchinson Cancer CenterP4BB (70)
Cyclosporin A
Anaplastic Large Cell Lymphoma
Fred Hutchinson Cancer CenterP2BB (68)
Methotrexate
Anaplastic Large Cell Lymphoma
Children's Cancer Group, ChinaP4BB (68)
Romidepsin
Anaplastic Large Cell Lymphoma
Walter HanelP2BB (68)
Lenalidomide
Anaplastic Large Cell Lymphoma
Children's Cancer Group, ChinaP3BB (66)
Prednisone
Anaplastic Large Cell Lymphoma
City of Hope Medical CenterP3BB (65)
Alectinib
Anaplastic Large Cell Lymphoma
Memorial Sloan Kettering Cancer CenterP2/3B (63)
Vinorelbine Ditartrate
Anaplastic Large Cell Lymphoma
Children's Cancer Group, ChinaP3B (63)
Pralatrexate
Anaplastic Large Cell Lymphoma
City of Hope Medical CenterP2B (61)
Nivolumab
Anaplastic Large Cell Lymphoma
National Cancer Institute (NCI)P2B (60)
Entrectinib
Anaplastic Large Cell Lymphoma
Hoffmann-La RocheP2CCC (53)
ICP34.5-, ICP47-DELETED HERPES SIMPLEX VIRUS 1 (HSV-1) INCORPORATING THE HUMAN GM-CSF GENE
Anaplastic Large Cell Lymphoma
National Cancer Institute (NCI)P2CCC (53)
Treosulfan
Anaplastic Large Cell Lymphoma
Fred Hutchinson Cancer CenterP2CCC (53)
azd3470
Anaplastic Large Cell Lymphoma
AstraZenecaP1/2CCC (48)
Pembrolizumab
Anaplastic Large Cell Lymphoma
AstraZenecaP1/2CCC (48)
Parsaclisib
Anaplastic Large Cell Lymphoma
Walter HanelP1CC (47)
Anti-Cd7 Car-T Cells
Anaplastic Large Cell Lymphoma
Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineP1CC (44)
Azacitidine
Anaplastic Large Cell Lymphoma
National Cancer Institute (NCI)P1CC (44)
Anti-Cd30 Bispecific Antibody-Armed Anti-Cd3-Activated Autologous T-Cells
Anaplastic Large Cell Lymphoma
Medical College of WisconsinP1CC (43)
Autologous T Cells Obtained From Peripheral Blood Mononuclear Cells By Leukapheresis, Transduced With A Self-Inactivating, Nonreplicating Lentiviral Vector, Encoding A T Cell Chimeric Antigen Receptor Targeting Cd19. The Expressed Transgene Comprises A Cd8? Leader Sequence, A Murine Anti-Cd19 Single Chain Variable Fragment (Scfv) Derived From The Mouse Hybridoma Fmc63, A Cd8? Hinge And Transmembrane Region, And A 4-1Bb (Cd137) And Cd3? (Tcr?) Signaling Domain And Is Under Control Of The Elongation Factor 1 Alpha (Ef1?) Promoter. The Construct Is Flanked By 5' And 3' Long Terminal Repeats (Ltrs) And Also Contains A ? Packaging Signal, A Rev Response Element (Rre), A Central Polypurine Tract (Cppt) Sequence And An Optimized Woodchuck Hepatitis Virus Posttranscriptional Regulatory Element (Wpre). The Leukapheresis Material Is Enriched For Cd4/Cd8 T Cells By Positive Immunoselection, Activated By Cd3 And Cd28 Agonists And Transduced With The Vector. Without Further Cell Propagation, The T Cells Are Washed, Formulated For Infusion, And Cryopreserved. The Substance Is Composed Of ?80% T Cells And ?1% B Cells, With A Mixture Of Transgene Positive (>3.4%) And Negative T Cells. The Cd4+ And Cd8+ Naïve T Cell Subsets (Cd45Ra+Ccr7+) Present In The Leukapheresis Material Are Largely Retained
Anaplastic Large Cell Lymphoma
Stanford UniversityP1CC (43)
c7r.cd30.car-ebvst cells
Anaplastic Large Cell Lymphoma
Baylor College of MedicineP1CC (43)
Gm-Csf
Anaplastic Large Cell Lymphoma
Medical College of WisconsinP1CC (43)
nkx019
Anaplastic Large Cell Lymphoma
Nkarta, Inc.P1CC (43)
PF-08046044
Anaplastic Large Cell Lymphoma
Seagen, a wholly owned subsidiary of PfizerP1CC (43)
pf-08046045
Anaplastic Large Cell Lymphoma
Seagen, a wholly owned subsidiary of PfizerP1CC (43)
Sgn-35
Anaplastic Large Cell Lymphoma
Seagen, a wholly owned subsidiary of PfizerP1CC (43)
Abatacept Recombinant
Anaplastic Large Cell Lymphoma
National Cancer Institute (NCI)P1CC (41)
Autologous Ccr4 Car T Cells
Anaplastic Large Cell Lymphoma
National Cancer Institute (NCI)P1CC (41)
cd30.car-t
Anaplastic Large Cell Lymphoma
Tessa TherapeuticsP1CC (41)
Duvelisib
Anaplastic Large Cell Lymphoma
Memorial Sloan Kettering Cancer CenterP1CC (41)
Immunoglobulin G4, Anti-(Human Programmed Cell Death Protein 1) (Human Monoclonal Regn2810 Heavy Chain), Disulfide With Human Monoclonal Regn2810 .Kappa.-Chain, Dimer
Anaplastic Large Cell Lymphoma
Mayo ClinicP1CC (41)
Lcar-Hl30 Cells
Anaplastic Large Cell Lymphoma
Ruijin HospitalP1CC (41)
Recombinant Vesicular Stomatitis Virus-Expressing Interferon-Beta
Anaplastic Large Cell Lymphoma
Mayo ClinicP1CC (41)
Ruxolitinib
Anaplastic Large Cell Lymphoma
Mayo ClinicP1CC (41)
Wu-Cart-007
Anaplastic Large Cell Lymphoma
Washington University School of MedicineP1CC (41)
Anti Cd30 Car-T Cell
Anaplastic Large Cell Lymphoma
Zhejiang UniversityEarly P1C (38)
Bexarotene
Anaplastic Large Cell Lymphoma
Case Comprehensive Cancer CenterN/AD (30)
Kenacort
Anaplastic Large Cell Lymphoma
Case Comprehensive Cancer CenterN/AD (30)
Nitrogen Mustard
Anaplastic Large Cell Lymphoma
Case Comprehensive Cancer CenterN/AD (30)